User Demands

IVTIP was in charge of collecting the needs of the end-users. For

that, a questionnaire was prepared and sent to all IVTIP members

and companies belonging to the IVTIP network. A series of new

approaches were proposed that could be summarised in three

aspects which should be improved:

 

(A) Need to increase complexity by the use of multimetric

end-points into the simple cellular models.

 

(B) Incorporate complex models in the testing battery.

 

(C) Implement more “human” testing models, more related to the

final target.

 

Future needs for in vitro testing

Technical approaches	%	New technologies	%
Simple studies (single end-point)	27	Genomics	39
Relatively complex studies (single end-point with different time-points or several end-points with a single time-point)	46	Proteomics Cellomics Metabolomics	24 15 15
Complex studies (several end-points with different timepoints)	27	Other	7

 

The models used by the final users today

 

The main objectives for using in vitro methods/models

 

 

Presentations at the Forum Event 2009

Testing needs and expectations: the importance of industrial applicability 

Bart De Wever and Erwin Roggen, IVTIP In Vitro Testing Industrial Platform, Belgium
Bart De Wever.pdf (200,9 kB)

The application of the 7th amendment: what models for what use?

Klaus Schroeder, Henkel AG & Co, Germany
Klaus Schroeder.pdf (625,2 kB)
 
Assuring safety without animal testing: Skin sensitisation case study 

Gavin Maxwell, Unilever, UK
Gavin Maxwell.pdf (4558,3 kB)